RepliCel Life Sciences Shares float
What is the Shares float of RepliCel Life Sciences?
The Shares float of RepliCel Life Sciences, Inc. is 20.365M 52.85%
What is the definition of Shares float?
Shares float is the portion of shares of a corporation that are in the hands of public investors as opposed to locked-in stock.
= annual shares outstanding - closely held shares
Shares float represents the portion of shares of a corporation that are in the hands of public investors as opposed to locked-in stock held by promoters, company officers, controlling-interest investors, or government. This number is sometimes seen as a better way of calculating market capitalization because it provides a more accurate reflection of what public investors consider the company to be worth. In this context, the float may refer to all the shares outstanding that can be publicly traded
The float is calculated by subtracting the locked-in shares from outstanding shares. Stocks with smaller floats tend to be more volatile than those with larger floats. In general, the large holdings of founding shareholders, corporate cross-holdings, and government holdings in partially privatized companies are excluded when calculating the size of a public float.
Shares float of companies in the Health Care sector on TSXV compared to RepliCel Life Sciences
What does RepliCel Life Sciences do?
RepliCel Life Sciences Inc., a regenerative medicine company, focuses on developing autologous cell therapies that treat functional cellular deficits. Its treatments use autologous cell therapy, which isolates an individual's own cells from harvested tissues and growing more in controlled conditions in a laboratory. The company's product candidates include RCT-01, which has completed Phase I clinical trials for the treatment of chronic tendinosis; RCS-01 that is in Phase 2 clinical trials to treat aging and sun damaged skin; and RCH-01, which is in Phase 2 clinical trials for the treatment of hair loss. It is also developing RCI-02, a dermal injection device. The company has a collaboration and technology transfer agreement with YOFOTO (China) Health Industry Co. Ltd. for establishing a clinical research program to develop and commercialize RCS-01 and RCT-01; and collaboration and technology transfer agreement with Shiseido Company, Limited for establishing a clinical research program for RCH-01. It also has a collaboration research project agreement with the University of British Columbia to build a hair follicle cell data map. RepliCel Life Sciences Inc. is headquartered in Vancouver, Canada.
Companies with shares float similar to RepliCel Life Sciences
- Apcotex Industries has Shares float of 20.294M 39.14%
- Taiga Motors has Shares float of 20.296M 65.06%
- Apcotex Industries has Shares float of 20.326M 39.21%
- Lok'nStore Plc has Shares float of 20.348M 67.88%
- High Liner Foods has Shares float of 20.351M 61.01%
- Surya Roshni has Shares float of 20.353M 37.41%
- RepliCel Life Sciences has Shares float of 20.365M 52.85%
- Immunodiagnostic Systems PLC has Shares float of 20.371M 70.77%
- Project Angel Parent has Shares float of 20.396M 25.35%
- Amesite has Shares float of 20.405M 92.81%
- Geyser Brands has Shares float of 20.407M 35.06%
- Dacian Gold has Shares float of 20.410M 1.68%
- Aurex has Shares float of 20.411M 85.26%